BioCentury | Jul 31, 2020
Distillery Therapeutics

MAO-B, GABRA5 identified as astrocyte targets in subcortical stroke

...At least four MAO-B inhibitors are marketed to treat Parkinson's disease (PD): Zelapar selegiline from Bausch Health Companies Inc....
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...CFO at Synergy Pharmaceuticals Inc., where he led the sale of the company’s assets to Bausch Health Companies Inc....
BioCentury | Sep 13, 2019
Clinical News

Sept. 13 Clinical Quick Takes: Amgen, Atara, MS biomarkers and switching in psoriasis

...ixekizumab from Eli Lilly and Co. (NYSE:LLY), Cosentyx secukinumab from Novartis and Siliq brodalumab from Bausch Health Companies Inc....
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

...known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch Health Companies Inc....
BioCentury | Aug 2, 2019
Finance

Earnings on deck

...hours in Tel Aviv Company Date Pre/post mkt 2Q19 EPS est 2Q18 EPS Expected chg Bausch Health Companies Inc....
BioCentury | Jun 21, 2019
Emerging Company Profile

Arcutis: Reformulating dermatology

...of new drugs in dermatology caused in part by large pharmas like Allergan plc and Valeant Pharmaceuticals...
...was president and CEO. Chaudhuri continued to served as president of Valeant (now known as Bausch Health Companies Inc....
...plc (NYSE:AGN), Dublin, Ireland Arcutis Inc., Westlake Village, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), Cambridge, U.K. Bausch Health Companies Inc....
BioCentury | May 29, 2019
Company News

CHMP against Emmaus' sickle cell therapy, Taiwan Liposome's doxorubicin

...from Univar Inc. (Bradford, U.K.) to treat Wilson disease in patients intolerant to D-penicillamine therapy. Bausch Health Companies Inc....
BioCentury | May 3, 2019
Finance

Earnings on deck

...exchange; (B) Fiscal 4Q; Company Date Pre/post mkt 1Q19 EPS est 1Q18 EPS Expected chg Bausch Health Companies Inc....
BioCentury | Apr 25, 2019
Company News

Salix licenses S1P receptor modulator from Mitsubishi

...from UCLA" ). Salix is a subsidiary of Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC). Mary Romeo, Staff Writer amiselimod (MT-1303) Plenvu (NER1006) Bausch Health Companies Inc. Biogen...
BioCentury | Apr 24, 2019
Financial News

Why Satsuma investors see room for another migraine therapy

...and could have efficacy advantages over Migranal, a nasal spray form of DHE marketed by Bausch Health Companies Inc....
Items per page:
1 - 10 of 911
BioCentury | Jul 31, 2020
Distillery Therapeutics

MAO-B, GABRA5 identified as astrocyte targets in subcortical stroke

...At least four MAO-B inhibitors are marketed to treat Parkinson's disease (PD): Zelapar selegiline from Bausch Health Companies Inc....
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...CFO at Synergy Pharmaceuticals Inc., where he led the sale of the company’s assets to Bausch Health Companies Inc....
BioCentury | Sep 13, 2019
Clinical News

Sept. 13 Clinical Quick Takes: Amgen, Atara, MS biomarkers and switching in psoriasis

...ixekizumab from Eli Lilly and Co. (NYSE:LLY), Cosentyx secukinumab from Novartis and Siliq brodalumab from Bausch Health Companies Inc....
BioCentury | Sep 6, 2019
Company News

Management tracks: Prometheus, Step, Spero, NorthSea, Aristea, MODAG and more

...known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch Health Companies Inc....
BioCentury | Aug 2, 2019
Finance

Earnings on deck

...hours in Tel Aviv Company Date Pre/post mkt 2Q19 EPS est 2Q18 EPS Expected chg Bausch Health Companies Inc....
BioCentury | Jun 21, 2019
Emerging Company Profile

Arcutis: Reformulating dermatology

...of new drugs in dermatology caused in part by large pharmas like Allergan plc and Valeant Pharmaceuticals...
...was president and CEO. Chaudhuri continued to served as president of Valeant (now known as Bausch Health Companies Inc....
...plc (NYSE:AGN), Dublin, Ireland Arcutis Inc., Westlake Village, Calif. AstraZeneca plc (LSE:AZN; NYSE:AZN), Cambridge, U.K. Bausch Health Companies Inc....
BioCentury | May 29, 2019
Company News

CHMP against Emmaus' sickle cell therapy, Taiwan Liposome's doxorubicin

...from Univar Inc. (Bradford, U.K.) to treat Wilson disease in patients intolerant to D-penicillamine therapy. Bausch Health Companies Inc....
BioCentury | May 3, 2019
Finance

Earnings on deck

...exchange; (B) Fiscal 4Q; Company Date Pre/post mkt 1Q19 EPS est 1Q18 EPS Expected chg Bausch Health Companies Inc....
BioCentury | Apr 25, 2019
Company News

Salix licenses S1P receptor modulator from Mitsubishi

...from UCLA" ). Salix is a subsidiary of Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC). Mary Romeo, Staff Writer amiselimod (MT-1303) Plenvu (NER1006) Bausch Health Companies Inc. Biogen...
BioCentury | Apr 24, 2019
Financial News

Why Satsuma investors see room for another migraine therapy

...and could have efficacy advantages over Migranal, a nasal spray form of DHE marketed by Bausch Health Companies Inc....
Items per page:
1 - 10 of 911